Glucocorticoid-mediated_JJ
inhibition_NN
of_IN
interleukin-2_NN
receptor_NN
alpha_NN
and_CC
-_JJ
beta_NN
subunit_NN
expression_NN
by_IN
human_JJ
T_NN
cells_NNS
._.

To_TO
determine_VB
the_DT
mechanism_NN
of_IN
glucocorticoid_NN
-LRB-_-LRB-
GC_NN
-RRB-_-RRB-
-_:
mediated_JJ
inhibition_NN
of_IN
T_NN
cell_NN
functions_NNS
,_,
the_DT
effect_NN
of_IN
dexamethasone_NN
-LRB-_-LRB-
DM_NN
-RRB-_-RRB-
on_IN
T_NN
cell_NN
proliferation_NN
and_CC
interleukin-2_NN
receptor_NN
-LRB-_-LRB-
IL-2R_NN
-RRB-_-RRB-
generation_NN
were_VBD
studied_VBN
._.

Dexamethasone_NN
inhibited_VBD
IL-2-induced_JJ
T_NN
cell_NN
proliferation_NN
by_IN
30_CD
%_NN
-_TO
88_CD
%_NN
,_,
relative_JJ
to_TO
its_PRP$
concentration_NN
within_IN
the_DT
cultures_NNS
._.

The_DT
effect_NN
of_IN
DM_NN
on_IN
expression_NN
of_IN
IL-2R_NN
alpha_NN
-LRB-_-LRB-
Tac_NN
,_,
p55_NN
,_,
CD25_NN
-RRB-_-RRB-
and_CC
beta_NN
-LRB-_-LRB-
p75_NN
-RRB-_-RRB-
genes_NNS
in_IN
activated_VBN
T_NN
cells_NNS
was_VBD
examined_VBN
next_RB
._.

In_IN
T_NN
cells_NNS
stimulated_VBN
with_IN
purified_VBN
phytohemagglutinin_NN
-LRB-_-LRB-
PHA-p_NN
-RRB-_-RRB-
and_CC
4_CD
beta-phorbol_NN
12-myristate_NN
13-acetate_NN
-LRB-_-LRB-
PMA_NN
-RRB-_-RRB-
addition_NN
of_IN
DM_NN
to_TO
the_DT
cultures_NNS
resulted_VBD
in_IN
a_DT
60_CD
%_NN
reduction_NN
in_IN
IL-2R_NN
alpha_NN
and_CC
a_DT
30_CD
%_NN
reduction_NN
in_IN
IL-2R_NN
beta_NN
membrane_NN
expression_NN
compared_VBN
to_TO
T_NN
cells_NNS
cultured_VBN
in_IN
the_DT
absence_NN
of_IN
DM_NN
-LRB-_-LRB-
p_NN
&lt;_JJR
0.01_CD
-RRB-_-RRB-
._.

Inhibition_NN
of_IN
membrane_NN
IL-2R_NN
alpha_NN
and_CC
IL-2R_NN
beta_NN
expression_NN
by_IN
10_CD
-LRB-_-LRB-
-6_CD
-RRB-_-RRB-
M_NN
DM_NN
was_VBD
partially_RB
reversible_JJ
by_IN
recombinant_JJ
human_JJ
IL-2_NN
-LRB-_-LRB-
rhIL-2_NN
-RRB-_-RRB-
._.

By_IN
Northern_NN
blot_NN
analysis_NN
,_,
DM_NN
caused_VBD
a_DT
comparable_JJ
decrease_NN
in_IN
IL-2R_NN
alpha_NN
and_CC
in_IN
IL-2R_NN
beta_NN
mRNA_NN
levels_NNS
to_TO
membrane_NN
receptor_NN
expression_NN
in_IN
mitogen-stimulated_JJ
T_NN
cells_NNS
._.

By_IN
in_FW
vitro_FW
transcription_NN
assays_NNS
,_,
DM_NN
regulated_VBD
IL-2R_NN
alpha_NN
gene_NN
expression_NN
at_IN
a_DT
transcriptional_JJ
level_NN
while_IN
transcription_NN
of_IN
IL-2R_NN
beta_NN
gene_NN
was_VBD
unaffected_JJ
by_IN
DM_NN
._.

The_DT
mechanism_NN
of_IN
action_NN
of_IN
DM_NN
on_IN
IL-2R_NN
alpha_NN
transcription_NN
was_VBD
examined_VBN
by_IN
determining_VBG
the_DT
mRNA_NN
levels_NNS
of_IN
the_DT
p50_NN
subunit_NN
of_IN
nuclear_JJ
factor_NN
kappa_NN
B_NN
-LRB-_-LRB-
NF-kappa_NN
B_NN
-RRB-_-RRB-
,_,
a_DT
transcription_NN
factor_NN
that_WDT
stimulates_VBZ
IL-2R_NN
alpha_NN
gene_NN
expression_NN
._.

The_DT
data_NNS
indicate_VBP
that_IN
10_CD
-LRB-_-LRB-
-6_CD
-RRB-_-RRB-
M_NN
DM_NN
increased_VBD
T_NN
cell_NN
p50_NN
NF-kappa_NN
B_NN
mRNA_NN
levels_NNS
by_IN
four-fold_JJ
compared_VBN
to_TO
the_DT
levels_NNS
obtained_VBN
in_IN
the_DT
absence_NN
of_IN
DM_NN
._.

Further_RB
,_,
the_DT
level_NN
of_IN
nuclear_JJ
proteins_NNS
capable_JJ
of_IN
binding_NN
to_TO
the_DT
NF-kappa_NN
B_NN
sites_NNS
in_IN
activated_VBN
T_NN
cells_NNS
increased_VBD
in_IN
response_NN
to_TO
DM_NN
._.

In_IN
sum_NN
,_,
DM_NN
regulates_VBZ
T_NN
cell_NN
membrane_NN
expression_NN
of_IN
IL-2R_NN
by_IN
more_JJR
than_IN
one_CD
molecular_JJ
mechanism_NN
._.

